Cargando…
Mutual Support of Ligand- and Structure-Based Approaches—To What Extent We Can Optimize the Power of Predictive Model? Case Study of Opioid Receptors
The process of modern drug design would not exist in the current form without computational methods. They are part of every stage of the drug design pipeline, supporting the search and optimization of new bioactive substances. Nevertheless, despite the great help that is offered by in silico strateg...
Autores principales: | Podlewska, Sabina, Kurczab, Rafał |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7998793/ https://www.ncbi.nlm.nih.gov/pubmed/33799356 http://dx.doi.org/10.3390/molecules26061607 |
Ejemplares similares
-
Surgery: To what extent can we operate?
por: Kakeji, Yoshihiro
Publicado: (2018) -
Mutual Enhancement of Opioid and Adrenergic Receptors by Combinations of Opioids and Adrenergic Ligands Is Reflected in Molecular Complementarity of Ligands: Drug Development Possibilities
por: Root-Bernstein, Robert, et al.
Publicado: (2019) -
How can SHAP values help to shape metabolic stability of chemical compounds?
por: Wojtuch, Agnieszka, et al.
Publicado: (2021) -
Molecular Modeling of µ Opioid Receptor Ligands with Various Functional Properties: PZM21, SR-17018, Morphine, and Fentanyl—Simulated Interaction Patterns Confronted with Experimental Data
por: Podlewska, Sabina, et al.
Publicado: (2020) -
How Sure Can We Be about ML Methods-Based Evaluation of Compound Activity: Incorporation of Information about Prediction Uncertainty Using Deep Learning Techniques
por: Sieradzki, Igor, et al.
Publicado: (2020)